ArticleJournal of experimental & clinical cancer research : CR2021

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.

Giulio Sartori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.